Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Louis H Miller

Showing results (101-110 of 168) with videos related to

Pageof 17
Sort By:
Vaccine|May 5, 2009
A Phase 1 study of the blood-stage malaria vaccine candidate AMA1-C1/Alhydrogel with CPG 7909, using two different formulations and dosing intervalsRuth D Ellis, Gregory E D Mullen, Mark Pierce, et al.
The Journal of Biological Chemistry|March 21, 2013
Structural and biochemical characterization of Plasmodium falciparum 12 (Pf12) reveals a unique interdomain organization and the potential for an antiparallel arrangement with Pf41Michelle L Tonkin, Silvia A Arredondo, Bianca C Loveless, et al.
Blood|April 29, 2004
The etiology of severe anemia in a village and a periurban area in MaliAlassane Dicko, Amy D Klion, Mahamadou A Théra, et al.
Proceedings of the National Academy of Sciences of the United States of America|December 6, 2018
MRI demonstrates glutamine antagonist-mediated reversal of cerebral malaria pathology in miceBrittany A Riggle, Sanhita Sinharay, William Schreiber-Stainthorp, et al.
Clinical and Vaccine Immunology : CVI|January 25, 2013
Identification of VAR2CSA domain-specific inhibitory antibodies of the Plasmodium falciparum erythrocyte membrane protein 1 using a novel flow cytometry assayHarold Obiakor, Marion Avril, Nicholas J Macdonald, et al.
Plos One|June 23, 2011
Non-apical membrane antigen 1 (AMA1) IgGs from Malian children interfere with functional activity of AMA1 IgGs as judged by growth inhibition assayKazutoyo Miura, Suwani Perera, Sarah Brockley, et al.
Journal of Immunology (Baltimore, Md. : 1950)|December 4, 2008
Comparison of biological activity of human anti-apical membrane antigen-1 antibodies induced by natural infection and vaccinationKazutoyo Miura, Hong Zhou, Samuel E Moretz, et al.
The American Journal of Tropical Medicine and Hygiene|February 3, 2021
Plasmodium vivax Infections Detected in a Large Number of Febrile Duffy-Negative Africans in Dschang, CameroonGhyslaine Bruna Djeunang Dongho, Karthigayan Gunalan, Mariangela L'Episcopia, et al.
Clinical and Vaccine Immunology : CVI|May 15, 2009
Anti-apical-membrane-antigen-1 antibody is more effective than anti-42-kilodalton-merozoite-surface-protein-1 antibody in inhibiting plasmodium falciparum growth, as determined by the in vitro growth inhibition assayKazutoyo Miura, Hong Zhou, Ababacar Diouf, et al.
Mbio|February 28, 2023
Cerebral Malaria Is Regulated by Host-Mediated Changes in <i>Plasmodium</i> Gene ExpressionClare K Cimperman, Mirna Pena, Sohret M Gokcek, et al.
Pageof 17

Showing results (101-110 of 168) with videos related to

Sort By:
Pageof 17
Vaccine|May 5, 2009
A Phase 1 study of the blood-stage malaria vaccine candidate AMA1-C1/Alhydrogel with CPG 7909, using two different formulations and dosing intervalsRuth D Ellis, Gregory E D Mullen, Mark Pierce, et al.
The Journal of Biological Chemistry|March 21, 2013
Structural and biochemical characterization of Plasmodium falciparum 12 (Pf12) reveals a unique interdomain organization and the potential for an antiparallel arrangement with Pf41Michelle L Tonkin, Silvia A Arredondo, Bianca C Loveless, et al.
Blood|April 29, 2004
The etiology of severe anemia in a village and a periurban area in MaliAlassane Dicko, Amy D Klion, Mahamadou A Théra, et al.
Proceedings of the National Academy of Sciences of the United States of America|December 6, 2018
MRI demonstrates glutamine antagonist-mediated reversal of cerebral malaria pathology in miceBrittany A Riggle, Sanhita Sinharay, William Schreiber-Stainthorp, et al.
Clinical and Vaccine Immunology : CVI|January 25, 2013
Identification of VAR2CSA domain-specific inhibitory antibodies of the Plasmodium falciparum erythrocyte membrane protein 1 using a novel flow cytometry assayHarold Obiakor, Marion Avril, Nicholas J Macdonald, et al.
Plos One|June 23, 2011
Non-apical membrane antigen 1 (AMA1) IgGs from Malian children interfere with functional activity of AMA1 IgGs as judged by growth inhibition assayKazutoyo Miura, Suwani Perera, Sarah Brockley, et al.
Journal of Immunology (Baltimore, Md. : 1950)|December 4, 2008
Comparison of biological activity of human anti-apical membrane antigen-1 antibodies induced by natural infection and vaccinationKazutoyo Miura, Hong Zhou, Samuel E Moretz, et al.
The American Journal of Tropical Medicine and Hygiene|February 3, 2021
Plasmodium vivax Infections Detected in a Large Number of Febrile Duffy-Negative Africans in Dschang, CameroonGhyslaine Bruna Djeunang Dongho, Karthigayan Gunalan, Mariangela L'Episcopia, et al.
Clinical and Vaccine Immunology : CVI|May 15, 2009
Anti-apical-membrane-antigen-1 antibody is more effective than anti-42-kilodalton-merozoite-surface-protein-1 antibody in inhibiting plasmodium falciparum growth, as determined by the in vitro growth inhibition assayKazutoyo Miura, Hong Zhou, Ababacar Diouf, et al.
Mbio|February 28, 2023
Cerebral Malaria Is Regulated by Host-Mediated Changes in <i>Plasmodium</i> Gene ExpressionClare K Cimperman, Mirna Pena, Sohret M Gokcek, et al.
Pageof 17